138 related articles for article (PubMed ID: 26110290)
1. Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?
De Rosa FG; Corcione S; Raviolo S; Montrucchio C; Aldieri C; Pagani N; Di Perri G
Infez Med; 2015 Jun; 23(2):105-16. PubMed ID: 26110290
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant infections in long-term care facilities: extended-spectrum β-lactamase-producing Enterobacteriaceae and hypervirulent antibiotic resistant Clostridium difficile.
Giufrè M; Accogli M; Ricchizzi E; Barbanti F; Farina C; Fazii P; Mattei R; Sarti M; Barozzi A; Buttazzi R; Cosentino M; Nardone M; Savini V; Spigaglia P; Moro ML; Cerquetti M
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):275-281. PubMed ID: 29571838
[TBL] [Abstract][Full Text] [Related]
3. Enteropathogenetic nosocomial infections: predisposing clinical characteristics and risk of recurrent infections.
Corcione S; Segala FV; Castiglione A; Lupia T; Angilletta R; Cavallo R; Ciccone G; De Rosa FG
J Chemother; 2019; 31(7-8):394-400. PubMed ID: 31556352
[TBL] [Abstract][Full Text] [Related]
4. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
Baur D; Gladstone BP; Burkert F; Carrara E; Foschi F; Döbele S; Tacconelli E
Lancet Infect Dis; 2017 Sep; 17(9):990-1001. PubMed ID: 28629876
[TBL] [Abstract][Full Text] [Related]
5. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
6. Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P; Cornaglia G
Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
[No Abstract] [Full Text] [Related]
7. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
[TBL] [Abstract][Full Text] [Related]
8. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
9. A Tale of Two Healthcare-associated Infections: Clostridium difficile Coinfection Among Patients With Candidemia.
Tsay S; Williams SR; Benedict K; Beldavs Z; Farley M; Harrison L; Schaffner W; Dumyati G; Blackstock A; Guh A; Vallabhaneni S
Clin Infect Dis; 2019 Feb; 68(4):676-679. PubMed ID: 30060067
[TBL] [Abstract][Full Text] [Related]
10. Updates in the epidemiology and management of candidemia and
Falcone M; Tiseo G; Venditti M; Menichetti F
Expert Rev Anti Infect Ther; 2019 May; 17(5):375-382. PubMed ID: 30982376
[No Abstract] [Full Text] [Related]
11. Prevalence and risk factors for colonization by Clostridium difficile and extended-spectrum β-lactamase-producing Enterobacteriaceae in rehabilitation clinics in Germany.
Arvand M; Ruscher C; Bettge-Weller G; Goltz M; Pfeifer Y
J Hosp Infect; 2018 Jan; 98(1):14-20. PubMed ID: 28705583
[TBL] [Abstract][Full Text] [Related]
12. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
[TBL] [Abstract][Full Text] [Related]
13. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemase-producing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting.
Aschbacher R; Giani T; Corda D; Conte V; Arena F; Pasquetto V; Scalzo K; Nicoletti M; Rossolini GM; Pagani E
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):354-6. PubMed ID: 24125922
[TBL] [Abstract][Full Text] [Related]
15. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
16. Should screening programs for carbapenemase-producing strains be implemented in ICU patients?
Oteo J
Enferm Infecc Microbiol Clin; 2017; 35(6):331-332. PubMed ID: 28104307
[No Abstract] [Full Text] [Related]
17. Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.
Russo A; Falcone M; Fantoni M; Murri R; Masucci L; Carfagna P; Ghezzi MC; Posteraro B; Sanguinetti M; Venditti M
Clin Microbiol Infect; 2015 May; 21(5):493.e1-4. PubMed ID: 25698658
[TBL] [Abstract][Full Text] [Related]
18. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial stewardship and Clostridium difficile-associated diarrhea.
Piacenti FJ; Leuthner KD
J Pharm Pract; 2013 Oct; 26(5):506-13. PubMed ID: 23946208
[TBL] [Abstract][Full Text] [Related]
20. Over-treatment of carbapenemase-producing Enterobacteriaceae.
Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
